Consolidated Balance Sheets - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Current Assets
Cash	$ 182,561	$ 232,984
Trade accounts receivable, net	444,743	154,436
Other receivables	2,250
Inventory, net	160,270	61,051
Total Current Assets	789,824	448,471
Current Liabilities
Accounts payable and accrued expenses	752,930	167,481
Derivative liabilities	192,254
Convertible notes payable	100,000
Notes payable, net of discount	106,365	100,000
Total Current Liabilities	1,151,549	267,481
Immudyne, Inc. Stockholders' Equity (Deficit)
Common stock, $0.01 par value; 50,000,000 shares authorized, 35,570,157 and 32,010,375 shares issued, 35,245,157 and 32,010,375 outstanding as of December 31, 2016 and 2015, respectively	355,701	320,103
Additional paid-in capital	9,070,064	8,366,313
Accumulated (deficit)	(9,693,882)	(8,586,338)
Equity	(268,117)	100,078
Treasury stock, 325,000 shares, at cost	(87,053)
Total Immudyne, Inc. Stockholders' Equity (Deficit)	(355,170)	100,078
Non-controlling interest	(6,555)	80,912
Total Stockholders' Equity (Deficit)	(361,725)	180,990
Total Liabilities and Stockholders' Equity (Deficit)	$ 789,824	$ 448,471

It represents total of common stock, additional paid in capital and accumulated deficit.

No definition available.

Name:	immd_Equity
Namespace Prefix:	immd_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.